Amsterdam, Northampton, 12 September 2024 - Normec, a leader in testing, inspection, certification and compliance (TICC) services, is excited to announce to partner with 20/30 Labs Limited. 20/30 is a leading provider of microbiological testing; with specialisms in medical device testing, medical device research, and water testing services. By partnering with 20/30 Labs Limited, Normec aims to expand its capabilities in the microbiological and environmental testing markets, addressing the growing demand for rigorous testing standards and compliance here and in related industries. This strategic partnership enhances Normec's service portfolio in the UK and strengthens its position as a comprehensive provider of testing solutions.
Founded in 2005, 20/30 Labs Limited has built a strong reputation for delivering reliable, high-quality testing solutions and has become a trusted partner for clients seeking to maintain stringent quality and safety standards. The company employs a team of skilled scientists and technicians who utilise state-of-the-art technology to ensure the highest levels of accuracy and compliance. The current leadership of 20/30 Labs will remain actively involved.
Joep Bruins, founder and CEO of Normec, commented: “As we entered the UK market last year, it has been our key priority to further strengthen our testing capabilities and presence in the UK. Our partnership with 20/30 Labs, one of the few accredited Medical Device testing laboratories, aligns perfectly with our vision. We look forward to working together with the team and their vast amounts of knowledge and expertise within the industry.”
Meredith Smart, the founder and Managing Director of 20/30: "I am excited for 20/30 to be joining Normec in the next stage of our journey. 20/30 has long had sophisticated capabilities - and we believe we will be able to unlock significant opportunities by being part of the Normec family. A shared vision and core values was a key factor in deciding to partner with Normec, and the team are looking forward to what lies ahead."
Normec were advised on the transaction by KPMG (financial and tax) and Avonhurst (legal). 20/30 Labs were advised by Anesi Advisors.
Normec:
Frederik Bernoski, General Counsel frederik.bernoski@normecgroup.com
Mike de Groot, Chief Investment Officer mike.de.groot@normecgroup.com
